« Return to News | CROs/Service Providers

LabConnect expands North American headquarters in Seattle

Wednesday, May 8, 2013 12:05 PM

LabConnect, a provider of global central laboratory testing services, is expanding its North American headquarters in Seattle. The success of LabConnect’s Scientific Operations Support (SciOps) team and overall company growth are behind its move to larger quarters in Seattle’s historic district.

“We needed to expand because we are growing,” said Eric Hayashi, president and CEO of LabConnect. “But beyond the additional space needed for our core office functions, we wanted to create just-in-time space for our growing SciOps team members who spend most of their time off site with clients. This move will give us room to double our capacity and allow us to better serve our clients.”

The SciOps team is a special unit comprised of industry experts with a minimum of 10 years of experience who offer short- or long-term functional outsourcing services for pharmaceutical research.

“Our customers want to focus on getting the job done well, not on the human resources aspects,” Hayashi said. “We help with both. We provide experienced research professionals and take care of all the details such as payroll and benefits. Demand for this service has been strong since the beginning and it is still growing.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.